10% Owner Files Intent to Sell Nearly $1 Million in Tenaya Therapeutics Shares

summarizeSummary

A major 10% institutional investor, COLUMN GROUP III-A, LP, has filed a Form 144 to sell an additional $985,362 in Tenaya Therapeutics common stock, continuing a pattern of significant share dispositions.

check_boxKey Events

• Intent to Sell Shares

  COLUMN GROUP III-A, LP, a 10% stockholder, filed a Form 144 to sell 1,591,090 shares of common stock, valued at approximately $985,362.04.

• Continuation of Recent Sales

  This filing follows previous dispositions by The Column Group and its affiliates, including over $3 million in sales reported on February 12, 2026, and other Form 144 filings in the past week, indicating an ongoing distribution strategy.

• Filer's Relationship

  The filer, COLUMN GROUP III-A, LP, is identified as a 10% stockholder of Tenaya Therapeutics, Inc.

auto_awesomeAnalysis

COLUMN GROUP III-A, LP, a 10% stockholder, has filed a Form 144 indicating its intent to sell approximately $985,362 worth of common stock. This follows a series of recent dispositions by The Column Group and its affiliates, including over $3 million in sales reported on February 12, 2026, and previous Form 144 filings. This continued intent to sell by a major institutional investor suggests ongoing distribution and could exert downward pressure on the stock.